COMBINATION THERAPY WITH A BET INHIBITOR, A BCL-2 INHIBITOR AND AN ANTI-CD20 ANTIBODY Application WO-2019020606-A1 World Intellectual Property Organisation (WIPO) 31 Jan 2019